Opaleye Management Inc. Q4 2024 Filing

Filed February 14, 2025

Portfolio Value

$571.4M

Holdings

39

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (39 positions)

#StockSharesValue% PortfolioType
1
HROWHARROW HEALTH INC
3,990,000$133.9M23.43%
2
TGTXTG THERAPEUTICS INC
2,260,000$68.0M11.90%
3
CDXSCODEXIS INC
8,840,000$42.2M7.38%
4
ETONETON PHARMACEUTICALS INC
2,852,070$38.0M6.65%
5
OCULOCULAR THERAPEUTIX INC
4,342,500$37.1M6.49%
6
ARVNARVINAS INC
1,625,000$33.6M5.89%
7
RYTMRHYTHM PHARMACEUTICALS INC
500,000$28.0M4.90%
8
IMNMIMMUNOME INC
2,040,000$21.7M3.79%
9
LQDALIQUIDIA CORPORATION
1,698,142$20.0M3.49%
10
EWTXEDGEWISE THERAPEUTICS INC
480,000$12.8M2.24%
11
DNAGINKGO BIOWORKS HOLDINGS
1,200,000$11.8M2.06%
12
CRGXCARGO THERAPEUTICS INC
750,000$10.8M1.89%
13
TARAPROTARA THERAPEUTICS INC
1,825,000$9.6M1.69%
14
TRVITREVI THERAPEUTICS INC
2,317,500$9.5M1.67%
15
JSPRJASPER THERAPEUTICS INC
400,000$8.6M1.50%
16
NAMSNEWAMSTERDAM PHARMA COMPANY
325,000$8.4M1.46%
17
SLRNACELYRIN INC
2,235,000$7.2M1.26%
18
NRIXNURIX THERAPEUTICS INC
378,500$7.1M1.25%
19
XOMAXOMA CORP DEL
250,000$6.6M1.15%
20
PCVXVAXCYTE INC
75,000$6.1M1.07%
21
GOSS 5 06/01/27GOSSAMER BIO INC
11,500,000$6.1M1.07%
22
ZNTLZENTALIS PHARMACEUTICALS INC
1,767,500$5.4M0.94%
23
BDSXBIODESIX INC
3,465,000$5.3M0.93%
24
KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC
6,000,000$4.7M0.82%
25
NUVLNUVALENT INC
58,500$4.6M0.80%
26
GOSSGOSSAMER BIO INC
4,490,000$4.1M0.71%
27
PTGXPROTAGONIST THERAPEUTICS INC
105,000$4.1M0.71%
28
EPIEURESSA PHARMA INC
2,209,998$4.0M0.69%
29
ABCLABCELLERA BIOLOGICS INC
965,000$2.8M0.49%
30
URGNUROGEN PHARMA LTD
220,000$2.3M0.41%
31
RZLTREZOLUTE INC
465,000$2.3M0.40%
32
IMTXIMMATICS NV
165,000$1.2M0.21%
33
IBIOIBIO INC
375,000$918K0.16%
34
LXEOLEXEO THERAPEUTICS INC
130,000$855K0.15%
35
RGNXREGENXBIO Inc
80,000$618K0.11%
36
VTYXVENTYX BIOSCIENCES
280,000$613K0.11%
37
PEPGPEPGEN INC
110,000$416K0.07%
38
STOKSTOKE THERAPEUTICS INC
25,000$275K0.05%
39
ADGMADAGIO MED HLDGS INC
110,571$116K0.02%